Cedara integrates 3D volume rendering

Article

Toronto-based Cedara Software has released the latest version of I-SoftView, integrating its proprietary form of 3D volume rendering, also known as Point and Click classification, into a PACS workstation. The implementation enables quick, automated

Toronto-based Cedara Software has released the latest version of I-SoftView, integrating its proprietary form of 3D volume rendering, also known as Point and Click classification, into a PACS workstation. The implementation enables quick, automated separation of tissues with minimum user interaction. Predefined protocols are applied and an image rendered with a single mouse click. The key benefit to end users and its major point of differentiation from other products in the market is the "intelligence" provided by the algorithm, which allows fast and automated recognition of anatomical structures. Another enhancement, called single media archiving, acts as an off-line archive, enabling the healthcare facility to store patient data on a magnetic optical disk (MOD) or CD. With this, users also have the option of giving patients a copy of their studies.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.